Clinical trial
Clinical Evaluation and Study on the Combination of Disease and Syndrome With General Treatment for Acute Hemorrhagic Stroke
NCT04946474 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation and Study on the Combination of Disease and Syndrome With General Treatment for Acute Hemorrhagic Stroke
- Lead sponsor
- Peking University Third Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 1, 2019
- Completion date
- September 1, 2021
- Enrollment
- 520 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute hemorrhagic stroke